Kailera Therapeutics Insider Acquires Additional 500,000 Shares for $8 Million
RTW Investments, a 10% owner of Kailera Therapeutics (KLRA), acquired 500,000 shares at $16 per share, totaling $8 million. The transaction occurred on April 20, 2026, and RTW's indirect ownership increased to 10,776,820 shares. The purchase price was significantly below the closing market price of $24.61, suggesting a favorable deal for RTW.
Topics: insider trading ownership changes SEC filings stock purchases